Home > Maligne hematologie > Lymfoïde ziekten > Plasmaceldyscrasieën > Multipel myeloom > Anakinra / AFFECT 2

Anakinra / AFFECT 2

Anakinra: Efficacy of interleukin-1 pathway inhibitor anakinra for the management of fever during neutropenia and mucositis in patients with multiple myeloma receiving an autologous hematopoietic stem cell transplantation after high-dose melphalan – A randomized controlled trial

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 29-5-2024, 1:30